Owner SENJU PHARMACEUTICAL CO., LTD. MITSUBISHI PHARMA CORPORATION

Inventors UEHATA, Masayoshi; YOSHIDA, Yukuo; TAKAYAMA, Yoshiko

Pub. Number AU-A-2002248005

PCT Pub. Number WO2002/083175

Priority 2001-308010 03.10.01 JP; 2001-113329 11.04.01 JP

Filing date 11 April 2002

Wipo publication date 28 October 2002

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/16 - Amides, e.g. hydroxamic acids

A61K 031/415 - 1,2-Diazoles

A61K 031/4375

A61K 031/52

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 031/505 - Pyrimidines

A61K 031/50 - Pyridazines

A61K 031/4545

A61K 031/444

A61K 031/4439

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 031/44 - Non-condensed pyridines

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 239/50 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/48 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 237/20 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 231/40 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 213/89 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/79 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 027/02 Drugs for disorders of the senses

A61P 025/00 Drugs for disorders of the nervous system

A61K 031/437

A61K 031/337 - having four-membered rings, e.g. taxol

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms